Compounding

Non-Sterile Compounding

The College has adopted the Model Standards for Pharmacy Compounding of Non-Sterile Preparations and the accompanying guidance document. This was approved by Council in December 2017.

The Non-Sterile Compounding Key Initiative page contains all of the College’s resources and information related to implementation of the standards, including:

In recognition of the evolving COVID-19 pandemic situation and the need for pharmacy professionals to focus on continuity of care and minimizing public risk, on March 23, 2020, Council approved an extension of the deadlines for pharmacies to meet the standards. The updated timelines for completion of each phase are:

  • Phase 1: January 1, 2020 – Assessing Risks and Gaps
  • Phase 2: July 1, 2021 – Personnel Training and Quality Assurance
  • Phase 3: January 1, 2022 – Facilities and Equipment

Although the deadlines for Phase 2 and 3 have been extended, it is the College’s expectation that pharmacies and pharmacy professionals continue to be engaged in preparing their pharmacy for full implementation of the standards.

Sterile Compounding

In September 2016, Council adopted the Model Standards for Non-hazardous Sterile Preparations (NAPRA, 2016) and the Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations (NAPRA, 2016) and approved implementation by January 1, 2019.

For resources and information related to the standards for sterile compounding, please visit the Sterile Compounding Key Initiative page.